Virginia Medicaid and semaglutide
Wegovy for weight loss: yes. Service authorization. BMI over 40, or over 37 with high cholesterol, high blood pressure or type 2 diabetes. Must have failed one non-GLP-1 weight-loss drug or be intolerant to all of them, and the provider attests obesity is disabling and life threatening. Ages by product. A separate form covers heart risk. Ozempic for weight loss: not confirmed; for type 2 diabetes Virginia Medicaid must cover it. Read from Virginia Department of Medical Assistance Services documents Nov 6, 2026.
In 2025 Virginia Medicaid paid for 55,560 semaglutide prescriptions (Ozempic, Wegovy, Rybelsus), 24% of its GLP-1 prescriptions and 19th of the 50 states and DC. It reimbursed $57.5 million before rebates, $1,036 a prescription against $1,104 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Ozempic | 28,955 | $26.1 million | $903 |
| Wegovy | 24,209 | $29.2 million | $1,205 |
| Rybelsus | 2,396 | $2.2 million | $924 |
Virginia plans and prescribing rules
Commonwealth of Virginia state employee health plan. Virginia's state employee health plans require a BMI of 35 or higher, plus prior authorization, for a weight-loss GLP-1 under the criteria announced for the 2026 open enrollment.
Semaglutide in the states around Virginia
| State | Sell semaglutide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Wegovy for weight loss |
|---|---|---|---|---|
| Virginia | 19 | $39/moWellmedr | 55,560 | Medicaid Wegovy: Yes |
| Kentucky | 19 | $39/moWellmedr | 179,878 | Medicaid Wegovy: No |
| Maryland | 19 | $39/moWellmedr | 109,871 | Medicaid Wegovy: No |
| North Carolina | 19 | $39/moWellmedr | 363,890 | Medicaid Wegovy: Yes |
| Tennessee | 18 | $39/moWellmedr | 86,329 | Medicaid Wegovy: Yes |
| West Virginia | 18 | $39/moWellmedr | 75,835 | Medicaid Wegovy: No |
| Washington, DC | not ranked | none verified | 16,469 | Medicaid Wegovy: No |



